JP2010518047A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010518047A5 JP2010518047A5 JP2009548691A JP2009548691A JP2010518047A5 JP 2010518047 A5 JP2010518047 A5 JP 2010518047A5 JP 2009548691 A JP2009548691 A JP 2009548691A JP 2009548691 A JP2009548691 A JP 2009548691A JP 2010518047 A5 JP2010518047 A5 JP 2010518047A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- heterocycloalkyl
- heteroaryl
- alkynyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07102027 | 2007-02-09 | ||
| EP08150003 | 2008-01-02 | ||
| PCT/EP2008/051527 WO2008095993A1 (en) | 2007-02-09 | 2008-02-07 | Novel nucleoside analogs for treatment of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010518047A JP2010518047A (ja) | 2010-05-27 |
| JP2010518047A5 true JP2010518047A5 (enExample) | 2011-03-31 |
Family
ID=39462074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548691A Pending JP2010518047A (ja) | 2007-02-09 | 2008-02-07 | ウイルス感染の処置のための新規なヌクレオシドアナログ |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8278282B2 (enExample) |
| EP (1) | EP2132216B1 (enExample) |
| JP (1) | JP2010518047A (enExample) |
| KR (1) | KR20090109102A (enExample) |
| CN (1) | CN101600726B (enExample) |
| AR (1) | AR065249A1 (enExample) |
| AT (1) | ATE533774T1 (enExample) |
| AU (1) | AU2008212752A1 (enExample) |
| BR (1) | BRPI0807222A2 (enExample) |
| CA (1) | CA2675462A1 (enExample) |
| CL (1) | CL2008000409A1 (enExample) |
| EA (1) | EA200901080A1 (enExample) |
| ES (1) | ES2381093T3 (enExample) |
| MX (1) | MX2009008495A (enExample) |
| PE (1) | PE20090070A1 (enExample) |
| PT (1) | PT2132216E (enExample) |
| TW (1) | TW200838550A (enExample) |
| WO (1) | WO2008095993A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR072906A1 (es) * | 2008-08-06 | 2010-09-29 | Novartis Ag | Nucleosidos modificados utiles como antivirales |
| CN102526087B (zh) * | 2010-12-30 | 2014-09-03 | 南开大学 | 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用 |
| CN105669783B (zh) * | 2014-12-03 | 2019-11-12 | 广东东阳光药业有限公司 | 一种制备呋喃糖的方法 |
| EP3331895B1 (en) | 2015-08-06 | 2020-07-29 | Chimerix, Inc. | Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents |
| CA2998646C (en) | 2015-09-23 | 2021-05-18 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof |
| CA3022119A1 (en) * | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| TW201815821A (zh) * | 2016-07-18 | 2018-05-01 | 美商再生元醫藥公司 | 抗茲卡病毒抗體及使用方法 |
| MA45925A (fr) * | 2016-08-12 | 2019-06-19 | Janssen Biopharma Inc | Nucléosides et nucléotides substitués et leurs analogues |
| ES3011607T3 (en) | 2017-09-21 | 2025-04-07 | Chimerix Inc | Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrrolo(2,3-d)pyrimidine-5-carboxamide and uses thereof |
| US11718534B2 (en) | 2019-04-23 | 2023-08-08 | Elementis Specialties, Inc. | Slurry compositions containing mixed branched alkyl organoclay compositions |
| AU2022422062B2 (en) * | 2021-12-22 | 2025-08-14 | Cj Cheiljedang Corporation | Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof |
| WO2024012568A1 (en) * | 2022-07-15 | 2024-01-18 | Sunshine Lake Pharma Co., Ltd. | A key intermediate for preparing glucopyranosyl derivatives and preparation method thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ3487A1 (fr) * | 2001-01-22 | 2002-07-25 | Merck Sharp & Dohme | Derives de nucleoside comme inhibiteurs de l'arn polymerase virale d'arn-dependant |
| WO2003051352A1 (en) * | 2001-12-14 | 2003-06-26 | Alcon, Inc. | Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| AU2003209045B2 (en) * | 2002-02-13 | 2006-12-14 | Isis Pharmaceuticals, Inc. | Methods of inhibiting orthopoxvirus replication with nucleoside compounds |
| RU2004135392A (ru) * | 2002-05-06 | 2005-06-27 | Дженелэбс Текнолоджиз, Инк. (Us) | Производные нуклеозидов для лечения инфекции, вызываемой вирусом гепатита с |
| KR20050059199A (ko) * | 2002-09-30 | 2005-06-17 | 제네랩스 테크놀로지스, 인코포레이티드 | Ｃ형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체 |
| US20040259934A1 (en) * | 2003-05-01 | 2004-12-23 | Olsen David B. | Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds |
| AU2004285923A1 (en) * | 2003-10-27 | 2005-05-12 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
-
2008
- 2008-02-05 TW TW097104689A patent/TW200838550A/zh unknown
- 2008-02-07 CN CN2008800031040A patent/CN101600726B/zh not_active Expired - Fee Related
- 2008-02-07 EP EP08708805A patent/EP2132216B1/en not_active Not-in-force
- 2008-02-07 AT AT08708805T patent/ATE533774T1/de active
- 2008-02-07 AU AU2008212752A patent/AU2008212752A1/en not_active Abandoned
- 2008-02-07 KR KR1020097016580A patent/KR20090109102A/ko not_active Ceased
- 2008-02-07 PE PE2008000274A patent/PE20090070A1/es not_active Application Discontinuation
- 2008-02-07 BR BRPI0807222-1A2A patent/BRPI0807222A2/pt not_active IP Right Cessation
- 2008-02-07 WO PCT/EP2008/051527 patent/WO2008095993A1/en not_active Ceased
- 2008-02-07 ES ES08708805T patent/ES2381093T3/es active Active
- 2008-02-07 US US12/526,079 patent/US8278282B2/en not_active Expired - Fee Related
- 2008-02-07 PT PT08708805T patent/PT2132216E/pt unknown
- 2008-02-07 JP JP2009548691A patent/JP2010518047A/ja active Pending
- 2008-02-07 MX MX2009008495A patent/MX2009008495A/es active IP Right Grant
- 2008-02-07 CA CA002675462A patent/CA2675462A1/en not_active Abandoned
- 2008-02-07 AR ARP080100529A patent/AR065249A1/es unknown
- 2008-02-07 EA EA200901080A patent/EA200901080A1/ru unknown
- 2008-02-08 CL CL200800409A patent/CL2008000409A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010518047A5 (enExample) | ||
| JP2011521903A5 (enExample) | ||
| JP2011518835A5 (enExample) | ||
| HRP20151075T1 (hr) | Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino) propanoat | |
| WO2008100447A3 (en) | Nucleoside analogs for antiviral treatment | |
| JP2007535496A5 (enExample) | ||
| WO2006046030A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| WO2007029029A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| JP2017505314A5 (enExample) | ||
| JP2011528713A5 (enExample) | ||
| WO2007070598A8 (en) | Nucleotide and oligonucleotide prodrugs | |
| JP2011525171A5 (enExample) | ||
| JP2012528161A5 (enExample) | ||
| JP2004516314A5 (enExample) | ||
| WO2007095269A3 (en) | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection | |
| EA200800178A1 (ru) | Ингибиторы вируса гепатита с (hcv) | |
| EP2368900A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| MA32633B1 (fr) | Formes cristallines d'un derive 2-thiazolyl-4-quinolinyl-oxy, un inhibiteur puissant du vhc | |
| EA200700338A1 (ru) | Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с и композиции и способы лечения с их использованием | |
| JP2010508362A5 (enExample) | ||
| EA201170915A1 (ru) | Фосфорамидатные производные гуанозиновых нуклеозидов для лечения вирусных инфекций | |
| ATE475660T1 (de) | Antivirale verbindungen | |
| PE20060837A1 (es) | COMPUESTOS DE 3H-OXAZOLO Y 3H-TIAZOLO[4,5-d]PIRIMIDIN-2-ONA 3,5-DISUSTITUIDA Y 3,5,7-TRISUSTITUIDA Y PROFARMACOS DE LOS MISMOS | |
| WO2008085508A3 (en) | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection | |
| JP2010532747A5 (enExample) |